Skip to main content
Top
Published in: Abdominal Radiology 3/2013

01-06-2013

Pancreaticobiliary disorders: comparison between magnetic resonance cholangiopancreatography images before and after fentanyl injection

Authors: Roohollah Abdi, Sima Fallah-Arzpeima

Published in: Abdominal Radiology | Issue 3/2013

Login to get access

Abstract

Objective

This study was designed to determine the effects of intravenous fentanyl on magnetic resonance cholangiopancreatography image quality in the treatment of pancreaticobiliary disorders.

Materials and methods

Forty consecutive patients referred for the evaluation of pancreaticobiliary disorders underwent magnetic resonance cholangiopancreatography in the coronal and oblique–coronal planes before and after fentanyl injection (every 2 up to 9 min). The images were analyzed qualitatively and quantitatively. Diameter and signal intensity were measured at the widest point and distal to the common bile duct and main pancreatic duct.

Results

The mean common bile duct diameters at the widest and distal points and mean pancreatic duct diameter were measured 7.53, 4.72, and 2.14 and 8.33, 5.35, and 2.57 before and after fentanyl injection, respectively. Mean signal intensity at the widest and distal point of the common bile duct and mean pancreatic duct signal intensity measured 278, 199, and 113 and 296, 218, and 121 before and after fentanyl injection, respectively. Minor improvements in image quality were detected qualitatively.

Conclusion

Fentanyl injection improves images qualitatively and quantitatively. In agreement with previous studies, our results confirm the beneficial effects of fentanyl as a simple adjunct to traditional magnetic resonance cholangiopancreatography.
Literature
1.
go back to reference Cohen SA, Siegel JH, Kasmin FE (1996) Complications of diagnostic and therapeutic ERCP. Abdom Imaging 21:385–394PubMedCrossRef Cohen SA, Siegel JH, Kasmin FE (1996) Complications of diagnostic and therapeutic ERCP. Abdom Imaging 21:385–394PubMedCrossRef
2.
go back to reference Duncan HD, Hodgkinson L, Deakin M, et al. (1997) The safety of diagnostic and therapeutic ERCP as a daycare procedure with a selective admission policy. Eur J Gastroentrol Hepatol 9:905–908CrossRef Duncan HD, Hodgkinson L, Deakin M, et al. (1997) The safety of diagnostic and therapeutic ERCP as a daycare procedure with a selective admission policy. Eur J Gastroentrol Hepatol 9:905–908CrossRef
3.
go back to reference Edelman R, Hesselink J, Zlatkin M, et al. (2006) Clinical magnetic resonance imaging; third edition. Philadelphia: Saunders Elsevier, pp 2483–2540 Edelman R, Hesselink J, Zlatkin M, et al. (2006) Clinical magnetic resonance imaging; third edition. Philadelphia: Saunders Elsevier, pp 2483–2540
4.
go back to reference Kaltenthaler EC, Walters SJ, Chilcott J, et al. (2006) MRCP compared to diagnostic ERCP for diagnosis when biliary obstruction is suspected: a systematic review. BMC Imaging 14:6–9 Kaltenthaler EC, Walters SJ, Chilcott J, et al. (2006) MRCP compared to diagnostic ERCP for diagnosis when biliary obstruction is suspected: a systematic review. BMC Imaging 14:6–9
5.
go back to reference Shanmugam V, Beattie GC, Yule SR, et al. (2005) Is magnetic resonance cholangiopancreatography the new gold standard in biliary imaging? Br J Radiol 78:888–893PubMedCrossRef Shanmugam V, Beattie GC, Yule SR, et al. (2005) Is magnetic resonance cholangiopancreatography the new gold standard in biliary imaging? Br J Radiol 78:888–893PubMedCrossRef
6.
go back to reference Silva AC, Friese JL, Hara AK, et al. (2004) MR cholangiopancreatography: improved ductal distention with intravenous morphine administration. Radiographics 24:677–687PubMedCrossRef Silva AC, Friese JL, Hara AK, et al. (2004) MR cholangiopancreatography: improved ductal distention with intravenous morphine administration. Radiographics 24:677–687PubMedCrossRef
7.
8.
go back to reference Agrawal S, Nag P, Sikora S, et al. (2006) Fentanyl-augmented MRCP. Abdom Imaging 31:582–587CrossRef Agrawal S, Nag P, Sikora S, et al. (2006) Fentanyl-augmented MRCP. Abdom Imaging 31:582–587CrossRef
9.
go back to reference Chu ZQ, Ji Q, Zhang Jl (2010) Orally administered lemon/orange juice improved MRCP imaging of pancreatic ducts. Abdom Imaging 35:367–371PubMedCrossRef Chu ZQ, Ji Q, Zhang Jl (2010) Orally administered lemon/orange juice improved MRCP imaging of pancreatic ducts. Abdom Imaging 35:367–371PubMedCrossRef
11.
go back to reference Fig LM, Wahl RL, Stewart RE, et al. (1990) Morphine-augmented hepatobiliary scintigraphy in the severely ill: caution is in order. Radiology 175(2):467–473PubMed Fig LM, Wahl RL, Stewart RE, et al. (1990) Morphine-augmented hepatobiliary scintigraphy in the severely ill: caution is in order. Radiology 175(2):467–473PubMed
12.
go back to reference Matos C, Metens T, Devière J, et al. (1997) Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 203:435–441PubMed Matos C, Metens T, Devière J, et al. (1997) Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 203:435–441PubMed
13.
go back to reference Manfredi R, Costamagna G, Brizi MG, et al. (2000) Sever chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 214:849–855PubMed Manfredi R, Costamagna G, Brizi MG, et al. (2000) Sever chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 214:849–855PubMed
14.
go back to reference Hellund JC, Skattum J, Buanes T, et al. (2007) Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticoboliary tract. Acta Radiol 48:135–141PubMedCrossRef Hellund JC, Skattum J, Buanes T, et al. (2007) Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticoboliary tract. Acta Radiol 48:135–141PubMedCrossRef
15.
go back to reference Czako L, Takacs T, Morvay Z, et al. (2004) Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Orv Hetil 145:529–534PubMed Czako L, Takacs T, Morvay Z, et al. (2004) Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Orv Hetil 145:529–534PubMed
16.
go back to reference Mc Cammon RL, Stoelting RK, Madura JA (1984) Effects of butorphanol, nalbuphine and fentanyl on intrabiliary tract dynamics. Anesth Analg 63:139–142 Mc Cammon RL, Stoelting RK, Madura JA (1984) Effects of butorphanol, nalbuphine and fentanyl on intrabiliary tract dynamics. Anesth Analg 63:139–142
Metadata
Title
Pancreaticobiliary disorders: comparison between magnetic resonance cholangiopancreatography images before and after fentanyl injection
Authors
Roohollah Abdi
Sima Fallah-Arzpeima
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9937-8

Other articles of this Issue 3/2013

Abdominal Radiology 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.